People take GLP-1 drugs like Wegovy, Ozempic, Mounjaro, and Zepbound for a variety of reasons, from controlling diabetes and sleep apnea to managing weight and enjoying benefits to the heart, liver, ...

A common class of drugs called anticholinergics might boost risks for heart failure and other dangerous cardiac conditions, a new study says. People taking the largest amounts of anticholinergic drugs ...

Weight-loss drugs may prevent deadly heart complications by opening blocked blood vessels after heart attacks, groundbreaking ...

Clinical and payer strategies should treat GLP‑1 therapy as chronic for high-risk patients, addressing tolerability and cost ...

People who use drugs with anticholinergic effects, including certain antidepressants, drugs for urinary incontinence and common antihistamines, are at higher risk of developing cardiovascular disease.

Commonly prescribed heart medications, including statins and diuretics, do not negatively affect the survival of ...

This little pill — taken by adults and children alike — might just be a prescription for heart disease. Speaking to The Post, the veteran heart doctor tackled a drug that is commonly prescribed to ...

TORONTO -- Biomarkers pointing to increased risk for Alzheimer's disease were markedly reduced with the investigational cholesteryl ester transfer protein (CETP) inhibitor obicetrapib relative to ...

A new study suggests heart health gains disappear in half the time it takes to build them up when people stop taking GLP-1 drugs like Ozempic.

A new study suggests that widely used GLP-1 weight-loss drugs may do more than improve metabolic health: they could also protect the heart after a heart attack. Doctors can often reopen the blocked ...